- Protocol Short Name and Number: CALGB 100104 / BMT CTN0704 Myeloma
- Protocol Long Name: A Phase III Randomized, Double-Blind Study of Maintenance Therapy With Cc-5013 (Nsc # 703813, Ind # 70116) Or Placebo Following Autologous Stem Cell Transplantation For Multiple Myeloma
- For access to Protocol documents please visit the CTSU site: https://www.ctsu.org
- Key Personnel
- BMT CTN # 0704 Protocol Chair: Phil McCarthy, MD
- BMT CTN # 0704 Protocol Chair: Kenneth Anderson, MD
- BMT CTN # 0704 Protocol Chair: Sergio Giralt, MD
- BMT CTN # 0704 Protocol Officer: Marcelo Pasquini, MD
- ECOG Protocol Chair: Philip Greipp, MD
- Alliance Regulatory Group: regulatory@alliancenctn.org
- Keywords: CALGB, 100104, Multiple Myeloma, MM, CC-5013, Maintenance
This study was closed to new patient accrual on July 2, 2009.